Experimental radioimmunotherapy with186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: Comparison with131I-counterpart
Experimental radioimmunotherapy with186Re-MAG3-A7 anti-colorectal cancer monoclonal antibody: Comparison with131I-counterpart
复制标题
186Re-MAG3-A7抗结直肠癌单克隆抗体实验性放射免疫治疗:与131I对应物的比较
DOI:
10.1007/bf02987831
复制
发表时间:
2001
影响因子:
2.6
通讯作者:
N. Tonami
中科院分区:
文献类型:
--
作者:
S. Kinuya;K. Yokoyama;K. Kobayashi;S. Motoishi;K. Onoma;N. Watanabe;N. Shuke;H. Bunko;T. Michigishi;N. Tonami
A murine IgG1 against aMr 45 kD tumor-associated glycoprotein in human colorectal cancer, A7, was radiolabeled with186Re by a chelating method with a mercaptoacetyltriglycine (MAG3). Its specific activity was 119 MBq/mg, which would be high enough for a therapeutic purpose, and its immunoreactivity was preserved well as was131I-A7 labeled by the chloramine-T method. Growth of human colon cancer xenografts, 9.14±0.44 mm in diameter, in nude mice was significantly suppressed by an intravenous dose of 4.48 MBq of186Re-A7. The therapeutic outcome with186Re-A7 was better than that with 4.63 MBq of131I-A7. Toxicity of treatments assessed by body weight change was similar with both conjugates. These results are likely caused by the tumor size and more favorable physical properties of186Re than those of131I.
登录
查看更多内容
影响因子:
158.5
作者:
KAMINSKI, MS;ZASADNY, KR;WAHL, RL
通讯作者:
WAHL, RL
影响因子:
11.2
作者:
Gary L. Griffiths;David M. Goldenberg;F. F. Knapp-F.;Alvin P. Callahan;Chien‐Hsing Chang;Hans J. Hansen
通讯作者:
Gary L. Griffiths;David M. Goldenberg;F. F. Knapp-F.;Alvin P. Callahan;Chien‐Hsing Chang;Hans J. Hansen
影响因子:
158.5
作者:
PRESS, OW;EARY, JF;BERNSTEIN, ID
通讯作者:
BERNSTEIN, ID
DOI:
10.1016/0883-2897(92)90009-n
发表时间:
1992
期刊:
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology
影响因子:
--
作者:
Najafi,A;Alauddin,MM;Sosa,A;Ma,GQ;Chen,DC;Epstein,AL;Siegel,ME
通讯作者:
Siegel,ME